Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-080313
Filing Date
2024-09-19
Accepted
2024-09-19 16:30:40
Documents
9

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0214747-s3_60degrees.htm S-3 465433
2 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea021474701ex5-1_60degrees.htm EX-5.1 12991
3 CLINICAL TRIAL AGREEMENT, DATED JULY 15, 2024, BETWEEN 60 DEGREES PHARMACEUTICAL ea021474701ex10-2_60degrees.htm EX-10.2 142736
4 CLINICAL TRIAL AGREEMENT, DATED JULY 15, 2024, BETWEEN 60 DEGREES PHARMACEUTICAL ea021474701ex10-3_60degrees.htm EX-10.3 145920
5 CONSENT OF RBSM LLP DATED AS OF SEPTEMBER 19, 2024 ea021474701ex23-1_60degrees.htm EX-23.1 2250
6 FILING FEE TABLE ea021474701ex-fee_60degrees.htm EX-FILING FEES 12998
7 GRAPHIC image_001.jpg GRAPHIC 12498
8 GRAPHIC image_002.jpg GRAPHIC 46101
9 GRAPHIC image_003.jpg GRAPHIC 5946
  Complete submission text file 0001213900-24-080313.txt   872690
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282221 | Film No.: 241310758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)